HEALTH DEBACLE
12/01/22 -"Health stocks (ex-Pharma) are competing with Semi-Conductors for the biggest loser spot. This is the by-product of trading at impossible multiples when the Fed is changing the game and raising rates. ..."
Pages
48
Language
English
Published on
12/01/22
You may also be interested by these reports :
06/02/26
Q4 ‘25 results exceeded consensus, as Lundbeck met its 2025 guidance. Strong growth for depression treatment Rexulti and migraine medicine Vyepti ...
05/02/26
The hugely discounted pricing announced by Hims & Hers for copycat pill versions of Novo’s semaglutide (for weight loss) seems perplexing, as they ...
05/02/26
The Q4 25 performance exceeded expectations, ensuring that GSK delivered on the higher end of the 2025 guidance. HIV, Respiratory, Immunology and ...
04/02/26
The Q4 performance, even though subdued, ensured that Novartis met the management’s 2025 guidance. Healthy Q4 growth across most key areas was ...